E-cadherin promoter hypermethylation induced by interleukin-1β treatment or H. pylori infection in human gastric cancer cell lines

Cancer Letters

Volumn 263, Issue 1, 2008, Pages 107-113

  Qian, Xuemin ^a,d   Huang, Camy ^a   Cho, Chi Hin ^b   Hui, Wai Mo ^a   Rashid, Asif ^c   Chan, Annie On On ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Department of Clinical Oncology   (Hong Kong)

Author keywords

CpG island methylation; Helicobacter pylori; Interleukin 1 ; Polymorphism

Indexed keywords

DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INFECTION COMPLICATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SEQUENCE ANALYSIS; STOMACH CANCER;

BASE SEQUENCE; CADHERINS; CELL LINE, TUMOR; DNA; DNA METHYLATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 41049086674     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.023     Document Type: Article

References (27)

1. Yamaoka Y., Kita M., Kodama T., Sawai N., Kashima K., and Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41 (1997) 442-451
2. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., and Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
3. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., Lanyon G., Martin M., Fraumeni Jr. J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
4. Chan A.O., Lam S.K., Wong B.C., Wong W.M., Yuen M.F., Yeung Y.H., Hui W.M., Rashid A., and Kwong Y.L. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 52 (2003) 502-506
5. Chan A.O., Peng J.Z., Lam S.K., Lai K.C., Yuen M.F., Cheung H.K., Kwong Y.L., Rashid A., Chan C.K., and Wong B.C. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 55 (2006) 463-468
6. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., Tamura G., Saito D., Sugimura T., Ichinose M., and Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 12 (2006) 989-995
7. Hmadcha A., Bedoya F.J., Sobrino F., and Pintado E. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J. Exp. Med. 190 (1999) 1595-1604
8. Chan A.O., Chu K.M., Huang C., Lam K.F., Leung S.Y., Sun Y.W., Ko S., Xia H.H., Cho C.H., Hui W.M., Lam S.K., and Rashid A. Association between Helicobacter pylori infection and interleukin 1beta polymorphism predispose to CpG island methylation in gastric cancer. Gut 56 (2007) 595-597
9. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol. Int. 50 (2000) 767-777
10. Otero M., Lago R., Lago F., Reino J.J., and Gualillo O. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res. Ther. 7 (2005) R581-R591
11. 2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem. 281 (2006) 1495-1505
12. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93 (1996) 9821-9826
13. Lewis A.M., Varghese S., Xu H., and Alexander H.R. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4 (2006) 48
14. Apte R.N., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y., Song X., Dvozkin T., Krelin Y., and Voronov E. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25 (2006) 387-408
15. Evans I., Dower S.K., Francis S.E., Crossman D.C., and Wilson H.L. Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway. Cytokine 33 (2006) 274-280
16. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., and Reeve A.E. E-cadherin germline mutations in familial gastric cancer. Nature 392 (1998) 402-405
17. Gayther S.A., Gorringe K.L., Ramus S.J., Huntsman D., Roviello F., Grehan N., Machado J.C., Pinto E., Seruca R., Halling K., MacLeod P., Powell S.M., Jackson C.E., Ponder B.A., and Caldas C. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 58 (1998) 4086-4089
18. Becker K.F., Atkinson M.J., Reich U., Becker I., Nekarda H., Siewert J.R., and Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54 (1994) 3845-3852
19. Veluthakal R., Amin R., and Kowluru A. Interleukin-1 beta induces posttranslational carboxymethylation and alterations in subnuclear distribution of lamin B in insulin-secreting RINm5F cells. Am. J. Physiol. Cell Physiol. 287 (2004) C1152-C1162
20. Veluthakal R., Wadzinski B.E., and Kowluru A. Localization of a nuclear serine/threonine protein phosphatase in insulin-secreting INS-1 cells: potential regulation by IL-1beta. Apoptosis (2006)
21. Fu S., Ramanujam K.S., Wong A., Fantry G.T., Drachenberg C.B., James S.P., Meltzer S.J., and Wilson K.T. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116 (1999) 1319-1329
22. Watanabe S., Takagi A., Koga Y., Kamiya S., and Miwa T. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide. J. Gastroenterol. Hepatol. 15 (2000) 168-174
23. Rajnakova A., Moochhala S., Goh P.M., and Ngoi S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett. 172 (2001) 177-185
24. Crabtree J.E., Ferrero R.L., and Kusters J.G. The mouse colonizing Helicobacter pylori strain SS1 may lack a functional cag pathogenicity island. Helicobacter 7 (2002) 139-140 author reply 140-1
25. Obonyo M., Guiney D.G., Fierer J., and Cole S.P. Interactions between inducible nitric oxide and other inflammatory mediators during Helicobacter pylori infection. Helicobacter 8 (2003) 495-502
26. Obonyo M., Cole S.P., Datta S.K., and Guiney D.G. Evidence for interleukin-1-independent stimulation of interleukin-12 and down-regulation by interleukin-10 in Helicobacter pylori-infected murine dendritic cells deficient in the interleukin-1 receptor. FEMS Immunol. Med. Microbiol. 47 (2006) 414-419
27. Kundu P., Mukhopadhyay A.K., Patra R., Banerjee A., Berg D.E., and Swarnakar S. Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J. Biol. Chem. 281 (2006) 34651-34662